How accurately does prostate biopsy Gleason score predict pathologic findings and disease free survival?

Area of Science:

• Urology
• Oncology
• Pathology

Background:

• Prostatectomy Gleason scores significantly impact prostate cancer prognosis.
• Subgrouping of Gleason scores (< 7, 7, > 7) is crucial for predicting outcomes.

Purpose of the Study:

• To determine if biopsy Gleason score predicts disease-free survival similarly to prostatectomy Gleason score.
• To assess the correlation between biopsy and prostatectomy Gleason scores in a contemporary prostatectomy series.

Main Methods:

• Analysis of 1,031 patients undergoing radical prostatectomy for localized prostate cancer.
• Prospective data collection with Gleason scores categorized (< 7, 7, > 7) for biopsy and prostatectomy specimens.
• Disease-free survival analysis based on categorized Gleason scores and evaluation of score discrepancies.

Main Results:

• Overall accuracy of Gleason score correlation between biopsy and prostatectomy was 58.3%.
• Both biopsy and prostatectomy Gleason scores significantly correlated with disease-free survival (P = 0.001).
• Patients with prostatectomy Gleason < 7 had a survival advantage over biopsy Gleason < 7 (P = 0.001), while biopsy Gleason > 7 showed superior survival than prostatectomy Gleason > 7 (P = 0.02).

Conclusions:

• Biopsy Gleason score is an important prognostic factor in prostate cancer, despite variable correlation with prostatectomy scores.
• Significant differences in disease-free survival are observed between biopsy and prostatectomy Gleason score categories.